Endo Luxembourg Finance I Company S.a.r.l. Credit Rating

Ergebnisse 1 - 50 von 65

Seite von 2 Next

Filtern nach:

Datum	Dokument-Art	Titel	Quelle
19 Aug 2022	Rating Action	Moody's downgrades Endo's PDR to D-PD following Chapter 11 filing	Moody's Investors Service
07 Jun 2022	LGD Assessment	Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
06 Jun 2022	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update following ratings downgrades on heightened restructuring risk	Moody's Investors Service
31 May 2022	Rating Action	Moody's downgrades Endo's ratings (CFR to Caa3, PDR to Ca-PD) on heightened restructuring risk	Moody's Investors Service
08 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
27 Aug 2021	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update to credit analysis following downgrade of CFR to Caa1	Moody's Investors Service
25 Aug 2021	Rating Action	Moody's downgrades Endo's CFR to Caa1; outlook negative	Moody's Investors Service
12 Aug 2021	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update to credit analysis - Vasostrict challenge and opioid litigation are key credit risks	Moody's Investors Service
07 Jul 2021	Covenant Quality Assessment	Endo Luxembourg Finance Company I S.à r.l.: Covenant Quality Post-Sale Snapshot: $1,295bn 6.125% Senior Secured Notes due 2029	Moody's Investors Service
11 Mar 2021	Rating Action	Moody's assigns B2 rating to Endo's proposed secured notes	Moody's Investors Service
04 Mar 2021	Rating Action	Moody's assigns B2 ratings to Endo's proposed credit facilities	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
14 Jul 2020	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update to credit analysis - Earnings pressure from coronavirus will increase leverage	Moody's Investors Service
14 May 2020	Rating Action	Moody's downgrades Endo's 1st lien secured debt to B2; assigns Caa2 rating to new 2nd lien secured notes; B3 CFR affirmed	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
02 Jul 2019	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update following downgrade to B3 CFR	Moody's Investors Service
01 Jul 2019	Rating Action	Moody's downgrades Endo's CFR to B3; outlook revised to stable	Moody's Investors Service
27 Mar 2019	Covenant Quality Assessment	Par Pharmaceutical, Inc.: Covenant Quality Post-Sale Snapshot: $1,500m 7.500% Senior Secured Notes due 2027	Moody's Investors Service
14 Mar 2019	Rating Action	Moody's downgrades Endo's secured debt to Ba3, unsecured notes to Caa1; B2 CFR affirmed	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Endo Luxembourg Finance I Company S.a.r.l	Moody's Investors Service
12 Dec 2018	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update to credit analysis	Moody's Investors Service
13 Jul 2018	LGD Assessment	Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
15 Dec 2017	Issuer In-Depth	Endo Luxembourg Finance I Company S.a.r.l.: FAQ about growth challenges, cash flow, and rising legal exposures	Moody's Investors Service
04 Dec 2017	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update following the outlook revision to negative from stable	Moody's Investors Service
29 Nov 2017	Rating Action	Moody's revises Endo's outlook to negative from stable; affirms ratings	Moody's Investors Service
04 Aug 2017	Covenant Quality Assessment	Endo Luxembourg Finance I Company S.a.r.l.: Loan Covenant Quality Snapshot	Moody's Investors Service
19 Jun 2017	Issuer Comment	FDA Asks Endo to Stop Selling an Opioid Painkiller, a Credit Negative	Moody's Investors Service
12 Jun 2017	Announcement	Moody's: Withdrawing Opana ER in the US following an FDA request would be credit negative for Endo	Moody's Investors Service
12 Jun 2017	Issuer Comment	Endo Luxembourg Finance I Company S.a.r.l.: Withdrawing Opana ER in the US following an FDA request would be credit negative for Endo	Moody's Investors Service
10 Apr 2017	Rating Action	Moody's rates Endo's new secured notes Ba2	Moody's Investors Service
07 Apr 2017	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update Following the Downgrade of the CFR to B2	Moody's Investors Service
04 Apr 2017	Rating Action	Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt	Moody's Investors Service
11 May 2016	LGD Assessment	Endo Luxembourg Finance I Company S.a.r.l. - Excel data	Moody's Investors Service
10 May 2016	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.: Update to Discussion of Key Credit Factors Following the Downgrade of the CFR to B1	Moody's Investors Service
06 May 2016	Rating Action	Moody's Downgrades Endo's Ratings; CFR to B1; outlook negative	Moody's Investors Service
31 Mar 2016	Issuer Comment	Generic Voltaren Gel Launch Is Credit Positive for Amneal and Negative for Endo	Moody's Investors Service
25 Mar 2016	Issuer Comment	Amneal Pharmaceuticals and Endo Luxembourg Finance Company: Generic Voltaren Gel launch is positive for Amneal and negative for Endo	Moody's Investors Service
29 Feb 2016	Announcement	Moody's: Endo's Increased Mesh Litigation Accrual is Credit Negative	Moody's Investors Service
29 Feb 2016	Issuer Comment	Endo Luxembourg Finance I Company S.a.r.l.: Increased Mesh Litigation Accrual is Credit Negative	Moody's Investors Service
09 Jul 2015	Credit Focus	Peer Comparison: Mallinckrodt Stronger Financially but Endo Has Lower Business Risk	Moody's Investors Service
25 Jun 2015	LGD Assessment	LGD Assessment: Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
17 Jun 2015	LGD Assessment	Endo LGD Asessment	Moody's Investors Service
12 Jun 2015	Credit Opinion	Endo Luxembourg Finance I Company S.a.r.l.	Moody's Investors Service
10 Jun 2015	Rating Action	Moody's Confirms Endo's CFR at Ba3; outlook negative	Moody's Investors Service
21 May 2015	Issuer Comment	Endo's Debt-Doubling Deal for Par Pharma Is Credit Negative	Moody's Investors Service
19 May 2015	Issuer Comment	Endo Luxembourg Finance I Company S.a.r.l: Endo’s Debt-Doubling Deal For Par Pharma Is Credit Negative	Moody's Investors Service
18 May 2015	Rating Action	Moody's reviews Endo's ratings for downgrade	Moody's Investors Service
17 Mar 2015	Rating Action	Moody's confirms Endo's Ba3 ratings; outlook stable	Moody's Investors Service
12 Mar 2015	Rating Action	Moody's reviews Endo's ratings for downgrade	Moody's Investors Service
02 Mar 2015	Announcement	Moody's: Endo's men's health divestiture is credit positive	Moody's Investors Service

Ergebnisse 1 - 50 von 65

Seite von 2 Next

Research & Ratings

Produkte & Lösungen

News & Events

Registrierter Nutzer

Noch nicht registriert?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: